MC
STDY

Menta Capital’s SteadyMed Ltd STDY Stock Holding History

Menta Capital’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-62,108
Closed -$279K – 798
2018
Q2 		$279K Buy
62,108
+47,400
+322% +$193K 0.07% 500
2018
Q1 		$48K Hold
14,708
– – 0.01% 611
2017
Q4 		$54K Sell
14,708
-396
-3% -$1.28K 0.01% 613
2017
Q3 		$51K Buy
+15,104
New +$80.3K 0.01% 735

Other funds holding STDY

AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Menta Capital's STDY Position: Q3 2018 in Review

Menta Capital sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 62,108 shares — an estimated $279K sold.

Menta Capital first reported a position in STDY in Q3 2017 and held it in 4 quarters. The position peaked at $279K in Q2 2018. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

  • Menta Capital reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
  • Menta Capital sold 62,108 SteadyMed Ltd shares in Q3 2018, an estimated $279K.
  • Menta Capital first reported a position in SteadyMed Ltd in Q3 2017 and held it in 4 quarters.
  • Menta Capital's SteadyMed Ltd position peaked at $279K in Q2 2018.
  • 5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on Menta Capital's 13F filing for Q3 2018, filed 14 Nov 2018.